Insmed, Inc. (INSM)
108.59
-5.55
(-4.86%)
USD |
NASDAQ |
Oct 01, 16:00
108.68
+0.09
(+0.08%)
After-Hours: 20:00
Insmed Price : 108.59 for Oct. 1, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 01, 2026 | 114.68 | 116.19 | 108.48 | 108.59 | 2.647M |
| Sep 30, 2026 | 115.65 | 116.43 | 113.60 | 114.14 | 2.870M |
| Sep 29, 2026 | 117.06 | 118.50 | 114.49 | 115.63 | 1.668M |
| Sep 28, 2026 | 116.82 | 119.32 | 116.31 | 117.67 | 1.744M |
| Sep 25, 2026 | 121.87 | 122.90 | 115.87 | 117.83 | 2.673M |
| Sep 24, 2026 | 119.26 | 121.69 | 118.38 | 121.55 | 2.234M |
| Sep 23, 2026 | 121.58 | 122.65 | 116.74 | 118.34 | 1.922M |
| Sep 22, 2026 | 121.00 | 122.48 | 119.09 | 120.82 | 2.405M |
| Sep 21, 2026 | 123.06 | 124.48 | 120.92 | 121.00 | 1.812M |
| Sep 18, 2026 | 123.89 | 124.11 | 119.32 | 120.00 | 3.445M |
| Sep 17, 2026 | 124.16 | 127.40 | 122.88 | 123.98 | 1.592M |
| Sep 16, 2026 | 120.00 | 124.41 | 119.55 | 122.58 | 1.434M |
| Sep 15, 2026 | 126.10 | 126.10 | 118.34 | 119.92 | 3.365M |
| Sep 14, 2026 | 129.50 | 130.78 | 124.58 | 125.30 | 1.611M |
| Sep 11, 2026 | 127.98 | 130.25 | 126.52 | 129.41 | 1.698M |
| Sep 10, 2026 | 127.22 | 128.85 | 124.29 | 127.28 | 2.595M |
| Sep 09, 2026 | 124.00 | 130.83 | 121.04 | 128.80 | 2.842M |
| Sep 08, 2026 | 124.78 | 127.42 | 121.38 | 124.89 | 1.605M |
| Sep 04, 2026 | 126.00 | 128.24 | 125.62 | 126.29 | 1.803M |
| Sep 03, 2026 | 126.70 | 127.09 | 124.05 | 126.68 | 1.886M |
| Sep 02, 2026 | 121.11 | 126.79 | 121.11 | 126.63 | 1.999M |
| Sep 01, 2026 | 121.95 | 122.19 | 119.52 | 121.51 | 1.419M |
| Aug 31, 2026 | 118.68 | 122.71 | 117.51 | 121.82 | 2.390M |
| Aug 28, 2026 | 120.11 | 120.66 | 117.15 | 118.54 | 1.978M |
| Aug 27, 2026 | 124.67 | 126.10 | 121.21 | 121.39 | 1.056M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 19.89 |
| Biogen, Inc. | 222.82 |
| Gilead Sciences, Inc. | 147.50 |
| Vertex Pharmaceuticals, Inc. | 506.74 |
| Agios Pharmaceuticals, Inc. | 32.48 |
Price Related Metrics
| PS Ratio | 20.48 |
| Price to Book Value | 31.29 |
| Earnings Yield | -3.78% |
| Market Cap | 23.70B |